Form D · Other Technology
EaglEyeMed, Inc.
San Jose, CA · CIK 0001583764
Offering snapshot reported Aug 6, 2013 · SEC filing
- Reported sold
- $600K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jun 19, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2013 | Initial | $600,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-200849
This filing covers the sale and issuance of Series Seed Preferred Stock and the underlying Common Stock issuable upon conversion thereof.
Source: Form D, filed Aug 6, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ravi Amble | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1172 Murphy Avenue, #229
San Jose, CA, 95131
San Jose, CA, 95131